QNTM receives FDA clearance to begin MS treatment trials
Quantum BioPharma Ltd. (NASDAQ: QNTM) received FDA clearance to begin trials for its MS treatment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.